Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,24116,260 of 20,252 grants

Active NON-SBIR/STTR RPGS
Development of 3-dimensional human pituitary corticotroph tumor cultures as a preclinical model for drug discovery
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2026

Abstract Cushing Disease (CD) is a life-threatening “orphan disease” caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma driving excess adrenal cortisol pro...

$3.39M
USD
Active NON-SBIR/STTR RPGS
Label-Free, Longitudinal, Multi-Metric Viability Imaging of 3D Tissue Spheroid Array
NATIONAL CANCER INSTITUTE Brown University United States 2021 – 2026

SUMMARY When selecting cancer therapy, physicians generally begin with first-line treatment options and monitor patient progress on a watch-and-wait basis, following a set of guide...

$3.32M
USD
Active NON-SBIR/STTR RPGS
Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2026

PROJECT SUMMARY Chimeric antigen receptor (CAR)-engineered T cell therapy has revolutionized treatment for certain B cell malignancies, but similar successes for acute myeloid leuk...

$4.65M
USD
Active NON-SBIR/STTR RPGS
Targeting Wnt signaling in therapy-resistant ovarian cancer
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2026

PROJECT SUMMARY PARP inhibitor (PARPi) use in the clinic is expanding into multiple cancer types, and consequently, PARPi resistance is a growing clinical problem. High grade serou...

$3.33M
USD
Active NON-SBIR/STTR RPGS
Targeting DKK-1 To Prevent Osteosarcoma Metastasis
NATIONAL CANCER INSTITUTE Albert Einstein College of Medicine United States 2021 – 2026

Abstract Osteosarcoma is the most common primary bone tumor of adolescents and young adults. Aggressive surgery and intensive chemotherapy provide long term survival to up to 75% o...

$6.31M
USD
Active NON-SBIR/STTR RPGS
Histone Deacetylation Signaling in Aging and Cancer Pathways
NATIONAL CANCER INSTITUTE Palo Alto Veterans Instit for Research United States 2021 – 2026

Our broad research goal is to understand chromatin regulatory mechanisms in nuclear and epigenetic programs and how these mechanisms are deregulated in aging and disease. A fundame...

$659K
USD
Active NON-SBIR/STTR RPGS
Targeting Wnt signaling in therapy-resistant ovarian cancer
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2026

PROJECT SUMMARY PARP inhibitor (PARPi) use in the clinic is expanding into multiple cancer types, and consequently, PARPi resistance is a growing clinical problem. High grade serou...

$793.3K
USD
Active NON-SBIR/STTR RPGS
Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2026

PROJECT SUMMARY AND ABSTRACT Metastatic castration-resistant prostate cancer (mCRPC) is the most lethal state of prostate cancer (PCa) and remains as the most challenging issue in...

$6.08M
USD
Active NON-SBIR/STTR RPGS
Identifying and engaging a universal adjuvant for breaking macrophage immune tolerance in cancer
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2026

Project Summary/Abstract The ability of cancer cells to evade immunosurveillance is one of the hallmarks of cancer. Understanding the mechanisms by which T, B and NK cells detect a...

$4.1M
USD
Completed NON-SBIR/STTR RPGS
Reviving cancer immune surveillance with CD4 T cell help
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2025

Abstract The immune system is capable of eliminating advanced malignant tumors, yet cancer immunotherapy success has been limited to a subset of cancer types. Conventional CD4, or...

$2.42M
USD
Active NON-SBIR/STTR RPGS
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy
NATIONAL CANCER INSTITUTE la Jolla Institute for Immunology United States 2021 – 2026

Project Summary Immune checkpoint blockade (ICB) therapy has demonstrated significant clinical benefit in late-stage patients with melanoma, renal cell carcinoma, head and neck can...

$6.59M
USD
Active NON-SBIR/STTR RPGS
Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2026

PROJECT SUMMARY AND ABSTRACT Metastatic castration-resistant prostate cancer (mCRPC) is the most lethal state of prostate cancer (PCa) and remains as the most challenging issue in...

$6.93M
USD
Completed NON-SBIR/STTR RPGS
Genome-wide Sequencing to Identify the Genes Responsible for Enchondromatoses and Related Malignant Tumors
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2023

Project Summary/Abstract We propose to investigate the molecular bases of Ollier disease (OD) and Maffucci syndrome (MS), rare diseases characterized by multiple enchondromas leadi...

$1.64M
USD
Active TRAINING, INDIVIDUAL
The Role of Glutamine Metabolism in Monocyte-Derived Dendritic Cell Differentiation in the Soft-Tissue Sarcoma Microenvironment
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2026

PROJECT SUMMARY Soft-tissue sarcomas (STS) are a diverse and often fatal set of malignancies arising from connective tissue with a 16% five-year survival rate for metastatic diseas...

$510.4K
USD
Active NON-SBIR/STTR RPGS
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy
NATIONAL CANCER INSTITUTE la Jolla Institute for Immunology United States 2021 – 2026

Project Summary Immune checkpoint blockade (ICB) therapy has demonstrated significant clinical benefit in late-stage patients with melanoma, renal cell carcinoma, head and neck can...

$7.83M
USD
Completed NON-SBIR/STTR RPGS
Dissecting drug resistance in serial uveal melanoma biopsies using integrated, multi-modal single-cell profiling and novel machine learning tools.
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2023

PROJECT SUMMARY Uveal melanoma (UM) is a rare melanoma subtype with an estimated annual incidence of approximately 2000 in the United States. While most patients have excellent rat...

$2.23M
USD
Completed NON-SBIR/STTR RPGS
Opioid-Sparing Interdisciplinary Interventions Addressing Pain in Head and Neck Cancer Patients
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2024

PROJECT SUMMARY BACKGROUND: For patients with head and neck cancer receiving radiation therapy (HNC), the frequency of substantial pain may be as high as 60 to 90% due to both the...

$1.86M
USD
Completed NON-SBIR/STTR RPGS
Reviving cancer immune surveillance with CD4 T cell help
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2025

Abstract The immune system is capable of eliminating advanced malignant tumors, yet cancer immunotherapy success has been limited to a subset of cancer types. Conventional CD4, or...

$2.49M
USD
Active NON-SBIR/STTR RPGS
Preclinical Electron Paramagnetic Resonance Tumor Imager
NATIONAL CANCER INSTITUTE University of Denver (Colorado Seminary United States 2021 – 2026

Summary Revolutionary methods of acquiring electron paramagnetic resonance (EPR) spectra of free radicals create a paradigm shift in application of EPR to understanding the role of...

$5.39M
USD
Completed OTHER RESEARCH-RELATED
Reviving cancer immune surveillance with CD4 T cell help
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2022

Abstract The immune system is capable of eliminating advanced malignant tumors, yet cancer immunotherapy success has been limited to a subset of cancer types.Conventional CD4, or `...

$1.05M
USD